Intellectual Property India Publishes Patent Application for 'Methods Of Treating Sarcoidosis With A Tnf-A- Antibody And Associated Compositions And Methods' Filed by Xentria, Inc.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202517063691 A) filed by Xentria, Inc., Chicago, on July 3, for 'methods of treating sarcoidosis with a tnf-a- antibody and associated compositions and methods.'

Inventor(s) include Anderson, Kirsten; Matthews, Thomas; Shea, Tom; and Singh, Noopur.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "Provided are compositions comprising an anti-TNFa antibody sialylated with one or more N-acetylneuraminic acid molecules, and associated methods. In some embodiments, provided are methods for treating or preventing sarcoidosis and/or granuloma size or formation in patients in need thereof."

The patent application was internationally filed on Dec. 08, 2023, under International application No.PCT/US2023/083191.

Disclaimer: Curated by HT Syndication.